NVAX

Novavax
NVAX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.23B
EV
$847.34M
Shares Outstanding
162.42M
Beta
2.50

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
$12.86
P/E 2025E
4.10x
P/Revenue 2025E
1.15x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Novavax, Inc.

gainify
NVAX

Novavax, Inc.

NVAX

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technol...

Sector

Healthcare

Industry

Biotechnology

CEO

Jacobs, John

Employees

952

IPO Date

1995-12-05

Headquarters

700 Quince Orchard Road, Gaithersburg, Maryland, 20878, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.